Meves Pharmaceuticals
New York, US · Founded 2016 · Delaware corporation
Find your way into Meves Pharmaceuticals
Sign up to see every warm intro you have to Meves Pharmaceuticals
- Paths you didn't know you had: your email and LinkedIn already hold routes to the Meves Pharmaceuticals team. We find them for you
- 2nd- and 3rd-degree connections: the friend-of-a-friend routes that take hours to manually find through your inbox or LinkedIn
- Answers now, not in days: momentum is everything in a raise. Skip asking around whether someone knows someone
Days of research, done the moment you sign in, with every route ranked by how warm it is.
Founders & leadership
RG
Rishi GuptaNamed on SEC filing
PB
Peter BarberNamed on SEC filing
JG
Joshua GrassNamed on SEC filing
BA
Ben AuspitzNamed on SEC filing
Reported raises · per SEC filings
Form D private placements$10.9M disclosed across 1 round · 2018
▶$10.9MraisedMar 2018 · 4 investors · PharmaceuticalsRule 506(b)
▶$10.9MraisedMar 2018 · 4 investors · Pharmaceuticals
Rule 506(b)Officers, directors & promoters on the filing
- Rishi GuptaDirector
- Peter BarberDirector
- Joshua GrassExecutive Officer, Director
- Ben AuspitzDirector
- Offering amount
- $30.9M
- Amount sold
- $10.9M
- First sale
- Mar 2018
- Incorporated
- Corporation, Delaware, 2016
- Federal exemptions
- 06b
Source: SEC EDGAR Form D. Amounts as filed; amended filings shown once at their latest values.
Frequently asked questions
- How much funding has Meves Pharmaceuticals raised?
- Meves Pharmaceuticals has disclosed $10.9M raised across 1 round.
- Where is Meves Pharmaceuticals headquartered?
- Meves Pharmaceuticals is headquartered in New York, US.